Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

3,664 public trials 791 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC

NCT04495153

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UConn Health Farmington, Connecticut, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NCT03620669

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Active, Not Recruiting

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06091943

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 15 locations
View Trial Details

Related conditions